Handbook of Lipoprotein Testing

Handbook of Lipoprotein Testing
Author :
Publisher : Amer. Assoc. for Clinical Chemistry
Total Pages : 848
Release :
ISBN-10 : 1890883352
ISBN-13 : 9781890883355
Rating : 4/5 (355 Downloads)

Book Synopsis Handbook of Lipoprotein Testing by : Nader Rifai

Download or read book Handbook of Lipoprotein Testing written by Nader Rifai and published by Amer. Assoc. for Clinical Chemistry. This book was released on 2000 with total page 848 pages. Available in PDF, EPUB and Kindle. Book excerpt:


Handbook of Lipoprotein Testing Related Books

Handbook of Lipoprotein Testing
Language: en
Pages: 848
Authors: Nader Rifai
Categories: Medical
Type: BOOK - Published: 2000 - Publisher: Amer. Assoc. for Clinical Chemistry

DOWNLOAD EBOOK

Handbook of Lipids in Human Function
Language: en
Pages: 0
Authors: Ronald Ross Watson
Categories: Technology & Engineering
Type: BOOK - Published: 2015-12-04 - Publisher: Academic Press and AOCS Press

DOWNLOAD EBOOK

Handbook of Lipids in Human Function: Fatty Acids presents current research relating to health issues whose impact may be modified by adopting personalized diet
Practicing Medicine Without a License?
Language: en
Pages: 258
Authors: Owen Fonorow
Categories: Medical
Type: BOOK - Published: 2008 - Publisher: Lulu.com

DOWNLOAD EBOOK

This book by the co-founder of the Vitamin C Foundation covers the greater than 50-year history of the vitamin C theory of heart disease as well as the 12-year
High Density Lipoproteins
Language: en
Pages: 0
Authors: Arnold von Eckardstein
Categories: Medical
Type: BOOK - Published: 2015-01-13 - Publisher: Springer

DOWNLOAD EBOOK

In this Handbook of Experimental Pharmacology on “High Density Lipoproteins – from biological understanding to clinical exploitation” contributing authors
Management of Dyslipidemia
Language: en
Pages: 176
Authors: Wilbert S. Aronow
Categories: Medical
Type: BOOK - Published: 2021-07-21 - Publisher: BoD – Books on Demand

DOWNLOAD EBOOK

Dyslipidemia is a major risk factor for cardiovascular events, cardiovascular mortality, and all-cause mortality. The earlier in life dyslipidemia is treated, t